: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Venous Thrombosis

Free Subscription

Articles published in Thromb Res
Retrieve available abstracts of 340 articles:
HTML format

Single Articles

April 2024

LOPEZ N, Zamora-Martinez C, Montoya-Rodes M, Gabara C, et al
Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital.
Thromb Res. 2024;236:136-143.
PubMed Abstract available

March 2024

MOKART D, Serre E, Bruneel F, Kouatchet A, et al
Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study.
Thromb Res. 2024;237:129-137.
PubMed Abstract available

GUTIERREZ-GUISADO J, Calvo-Sotelo AE, Hernandez-Blasco L, Fidalgo A, et al
Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.
Thromb Res. 2024;237:94-99.
PubMed Abstract available

BAASTRUP NN, Buch AK, Gundestrup AK, Olsen ASF, et al
The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery programme.
Thromb Res. 2024;237:46-51.
PubMed Abstract available

LUTFI A, O'Rourke E, Crowley M, Craig E, et al
VTE risk assessment, prevention and diagnosis in pregnancy.
Thromb Res. 2024;235:164-174.
PubMed Abstract available

February 2024

OGIHARA Y, Yamashita Y, Morimoto T, Chatani R, et al
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
Thromb Res. 2024;236:191-200.
PubMed Abstract available

FLYNN C, Baldassarra J, Hamidi A
Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study.
Thromb Res. 2024;236:127-129.
PubMed

RAJPURKAR M, Rosovsky RP, Williams S, Chan AKC, et al
Considerations for instituting pediatric pulmonary embolism response teams: A tool kit.
Thromb Res. 2024;236:97-107.
PubMed Abstract available

BHANGU G, Murray A, Qayyum A, Goumeniouk N, et al
Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review.
Thromb Res. 2024;236:108-116.
PubMed Abstract available

SIMARD C, Poirier-Blanchette L, Rizzolo A, Cafaro T, et al
Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative.
Thromb Res. 2024;236:68-73.
PubMed Abstract available

BAO L, Fang LJ, Xiao MY, Lu MQ, et al
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study.
Thromb Res. 2024;236:130-135.
PubMed Abstract available

VAN OMMEN CH, Luijnenburg SE
Anticoagulation of pediatric patients with venous thromboembolism in 2023.
Thromb Res. 2024 Feb 10:S0049-3848(24)00032.
PubMed Abstract available

January 2024

FAN Z, Xu S, Deng Y, Wei L, et al
Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism.
Thromb Res. 2024;235:68-74.
PubMed Abstract available

CHAIBI S, Roy PM, Guenegou AA, Tran Y, et al
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial.
Thromb Res. 2024;235:79-87.
PubMed Abstract available

YOO J, Jeon J, Baik M, Kim J, et al
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study.
Thromb Res. 2024;235:32-40.
PubMed Abstract available

CHOPARD R, Bertoletti L, Piazza G, Jimenez D, et al
External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry.
Thromb Res. 2024;235:22-31.
PubMed Abstract available

ABDULREHMAN J, Harrigan A, Simard C, Tagalakis V, et al
TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.
Thromb Res. 2024;235:11-14.
PubMed

ABRAHAO R, Brunson A, Chubak J, Wernli KJ, et al
Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
Thromb Res. 2024;235:1-7.
PubMed Abstract available

CASPERSEN CK, Ingemann-Molden S, Grove EL, Hojen AA, et al
Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review.
Thromb Res. 2024;235:52-67.
PubMed Abstract available

TIRATRAKOONSEREE T, Charoenpichitnun S, Natesirinilkul R, Songthawee N, et al
Clinical prediction tool to identify children at risk of pulmonary embolism.
Thromb Res. 2024;234:151-157.
PubMed Abstract available

HOUGHTON DE, Casanegra AI, Wysokinski WE, Padrnos LJ, et al
COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds.
Thromb Res. 2024;235:8-10.
PubMed

YAN AR, Samarawickrema I, Naunton M, Peterson GM, et al
Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
Thromb Res. 2024;234:120-133.
PubMed Abstract available

CHATANI R, Yamashita Y, Morimoto T, Mushiake K, et al
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
Thromb Res. 2024;234:86-93.
PubMed Abstract available

December 2023

OBRADOVIC S, Dzudovic B, Simpson T, Matijasevic J, et al
S wave resolution in lead aVL at 48 hours after pulmonary embolism admission predicts lower mortality.
Thromb Res. 2023;234:36-38.
PubMed

GUMAN NAM, Kaptein FHJ, Lohle SB, Mairuhu ATA, et al
Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: A multicenter retrospective cohort study.
Thromb Res. 2023;233:181-188.
PubMed Abstract available

PUCHADES R, Tung-Chen Y, Salgueiro G, Lorenzo A, et al
Artificial intelligence for predicting pulmonary embolism: A review of machine learning approaches and performance evaluation.
Thromb Res. 2023;234:9-11.
PubMed

RUEDA-CAMINO JA, Barba R, Otalora S, Bura-Riviere A, et al
Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism.
Thromb Res. 2023;233:165-172.
PubMed Abstract available

FRENZEL L, Decaux O, Macro M, Belhadj-Merzoug K, et al
Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
Thromb Res. 2023;233:153-164.
PubMed Abstract available

TRITSCHLER T, Sadeghipour P, Bikdeli B
Subgroup analysis in randomized controlled trials: Useful or misleading?
Thromb Res. 2023;232:160-162.
PubMed

November 2023

LIPPI G, Mattiuzzi C, Favaloro EJ
Recent monthly mortality for pulmonary embolism in the US.
Thromb Res. 2023;233:99-100.
PubMed

INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
Thromb Res. 2023;233:69-81.
PubMed Abstract available

NAJARRO M, Briceno W, Rodriguez C, Muriel A, et al
Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism.
Thromb Res. 2023;233:18-24.
PubMed Abstract available

APARICIO I, Iranzo P, Reyes R, Bote H, et al
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Thromb Res. 2023;232:133-137.
PubMed Abstract available

CHEN AC, Rao AS, Oropallo A, Goldhaber SZ, et al
Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Thromb Res. 2023;232:123-132.
PubMed Abstract available

HEERINK JS, Oudega R, Gemen E, Hopstaken R, et al
Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism.
Thromb Res. 2023;232:113-122.
PubMed Abstract available

ZABCZYK M, Kruk A, Natorska J, Undas A, et al
Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
Thromb Res. 2023;232:70-76.
PubMed Abstract available

BIKDELI B, Piazza G
The CORONA-VTE network registry: Revisiting the realities while encouraging enthusiasm.
Thromb Res. 2023;231:7.
PubMed

October 2023

PAREDES D, Del Carmen Diaz-Pedroche M, Gomez-Cuervo C, Perez-Jacoiste A, et al
Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism.
Thromb Res. 2023;232:54-61.
PubMed Abstract available

KAPTEIJN MY, Lanting VR, Kaptein FHJ, Guman NAM, et al
RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
Thromb Res. 2023;232:27-34.
PubMed Abstract available

TSUJISAKA Y, Yamashita Y, Morimoto T, Takase T, et al
Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
Thromb Res. 2023;232:35-42.
PubMed Abstract available

ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
Thromb Res. 2023;231:91-98.
PubMed Abstract available

YHIM HY, Lee J, Kim KH, Kim SA, et al
Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
Thromb Res. 2023;231:50-57.
PubMed Abstract available

September 2023

MAVROMANOLI AC, Jimenez D, Sanchez O, Sobkowicz B, et al
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
Thromb Res. 2023;231:29-31.
PubMed

RAMBAUD G, Mai V, Motreff C, Sanchez O, et al
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
Thromb Res. 2023;231:58-64.
PubMed Abstract available

XU Y, Khan F, Kovacs MJ, Sabri E, et al
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
Thromb Res. 2023;231:32-38.
PubMed Abstract available

DRAGSBAEK SJ, Lyhne MD, Hansen JV, Pedersen CCE, et al
A porcine model of human-like chronic thromboembolic pulmonary disease.
Thromb Res. 2023;231:25-28.
PubMed

STALS MAM, Beenen LFM, Coppens M, Faber LM, et al
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
Thromb Res. 2023;231:65-75.
PubMed Abstract available

AVERY J, Guffey D, Ma S, Basom R, et al
Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Thromb Res. 2023;229:1-6.
PubMed Abstract available

August 2023

CHU G, Seelig J, Cannegieter SC, Gelderblom H, et al
Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
Thromb Res. 2023;230:98-104.
PubMed Abstract available

SCOTT DM, Abud A, Amor M, Saemi A, et al
Natural Language Processing tool accurately identifies acute venous thromboembolism.
Thromb Res. 2023;229:252-254.
PubMed

FELIX G, Ferreira E, Ribeiro A, Guerreiro I, et al
Predictors of cancer in patients with acute pulmonary embolism.
Thromb Res. 2023;230:11-17.
PubMed Abstract available

July 2023

MEYER HJ, Gottschling S, Bar C, Wienke A, et al
CT coronary calcium score is a prognostic marker in acute pulmonary embolism.
Thromb Res. 2023;229:255-257.
PubMed

BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
Thromb Res. 2023;229:139-145.
PubMed Abstract available

ANIJS RJS, Chen Q, van der Hulle T, Versteeg HH, et al
Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
Thromb Res. 2023;229:90-98.
PubMed Abstract available

ALMAJDI A, Almutairi S, Alharbi M
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis.
Thromb Res. 2023;229:77-85.
PubMed Abstract available

HYDER SN, Han HB, Ash S, Horne BD, et al
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
Thromb Res. 2023;227:45-50.
PubMed Abstract available

June 2023

LOWE G, Wu O, van Hylckama Vlieg A, Folsom A, et al
Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.
Thromb Res. 2023;229:31-39.
PubMed Abstract available

FILIPPI L, Turcato G, Milan M, Barbar S, et al
Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.
Thromb Res. 2023;229:73-76.
PubMed Abstract available

JERVAN O, Dhayyat A, Gleditsch J, Haukeland-Parker S, et al
Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism.
Thromb Res. 2023;229:7-14.
PubMed Abstract available

MUNOZ AJ, Souto JC, Lecumberri R, Obispo B, et al
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
Thromb Res. 2023;228:181-188.
PubMed Abstract available

JAOUEN S, Mingant F, Lippert E, Galinat H, et al
Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
Thromb Res. 2023;228:191-199.
PubMed Abstract available

ZUIN M, Bikdeli B, Davies J, Krishnathasan D, et al
Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019.
Thromb Res. 2023;228:72-80.
PubMed Abstract available

BROWN C, Brandt W, Wang TF, Delluc A, et al
Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
Thromb Res. 2023;228:81-84.
PubMed Abstract available

May 2023

OTERO R, Lobo JL, Lopez R, Fernandez C, et al
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
Thromb Res. 2023;228:1-9.
PubMed Abstract available

ADDA-REZIG I, Cossu J, Falvo N, Ecarnot F, et al
Home treatment versus early discharge for the outpatient management of acute pulmonary embolism: A non-interventional, post-hoc cohort analysis.
Thromb Res. 2023;227:25-33.
PubMed Abstract available

PALLARES ROBLES A, Ten Cate V, Lenz M, Schulz A, et al
Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification.
Thromb Res. 2023 May 8:S0049-3848(23)00124.
PubMed Abstract available

April 2023

LI HY, Wang J, Wang T, Wang HS, et al
Management of venous thromboembolism in pediatric patients: Quality assessment of clinical practice guidelines and variations in recommendations.
Thromb Res. 2023;226:107-116.
PubMed Abstract available

CHIU J, Lazo-Langner A
Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review.
Thromb Res. 2023;226:141-149.
PubMed Abstract available

DROPPA M, Zdanyte M, Henes JK, Gawaz M, et al
Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis.
Thromb Res. 2023;226:33-35.
PubMed

KAPTEIN FHJ, Kroft LJM, van Dam LF, Stoger JL, et al
Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes.
Thromb Res. 2023;226:51-55.
PubMed Abstract available

KELLER K, Kohring C, Farmakis IT, Valerio L, et al
Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
Thromb Res. 2023;226:9-17.
PubMed Abstract available

QIAO N, Zhang Q, Chen L, He W, et al
Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
Thromb Res. 2023;226:1-8.
PubMed Abstract available

COHEN A, Noxon V, Dhamane A, Bruette R, et al
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
Thromb Res. 2023;226:117-126.
PubMed Abstract available

March 2023

ZBINDEN S, Voci D, Grigorean A, Holy EW, et al
Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism.
Thromb Res. 2023;225:73-78.
PubMed Abstract available

MATUSOV Y, Yaqoob M, Karumanchi A, Lipshutz HG, et al
Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
Thromb Res. 2023;225:57-62.
PubMed Abstract available

KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
PubMed

ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
Thromb Res. 2023;225:28-32.
PubMed Abstract available

February 2023

WIKLUND P, Medson K, Elf J
Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
Thromb Res. 2023;224:65-72.
PubMed Abstract available

PRANDONI P, Bilora F, Mahe I, Varona JF, et al
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
Thromb Res. 2023;224:17-20.
PubMed

ROHATGI N, Dahlen A, Berube C, Weng Y, et al
Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015-2019).
Thromb Res. 2023;224:4-12.
PubMed Abstract available

ZHANG C, Deng Z, Yang Z, Xie J, et al
A nomogram model to predict the acute venous thromboembolism risk after surgery in patients with glioma.
Thromb Res. 2023;224:21-31.
PubMed Abstract available

VOSTATEK R, Hohensinner P, Nopp S, Haider P, et al
Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism.
Thromb Res. 2023;223:168-173.
PubMed Abstract available

January 2023

MIRAMBEAUX R, Rodriguez C, Muriel A, Gonzalez S, et al
Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism.
Thromb Res. 2023;223:61-68.
PubMed Abstract available

ANDO K, Natsumeda M, Kawamura M, Shirakawa K, et al
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
Thromb Res. 2023;223:36-43.
PubMed Abstract available

CIRES-DROUET R, LaRocco A, Soldin D, John T, et al
Left ventricular systolic dysfunction during acute pulmonary embolism.
Thromb Res. 2023;223:1-6.
PubMed Abstract available

OGUNSOLA AS, Farhadi K, Mercy UC, Elenwa F, et al
Analysis of contemporary mortality trends in pulmonary embolism, United States, 1999-2020.
Thromb Res. 2023;223:53-60.
PubMed Abstract available

KONG J, Hardwick A, Jiang SF, Sun K, et al
CTEPH: A Kaiser Permanente Northern California Experience.
Thromb Res. 2023;221:130-136.
PubMed Abstract available

ZHENG C, Ma J, Xu J, Wu L, et al
The optimal regimen, efficacy and safety of tranexamic acid and aminocaproic acid to reduce bleeding for patients after total hip arthroplasty: A systematic review and Bayesian network meta-analysis.
Thromb Res. 2023;221:120-129.
PubMed Abstract available

December 2022

CHOPARD R, Campia U, Jering KS, Almarzooq ZI, et al
Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center.
Thromb Res. 2022;222:113-116.
PubMed

FISCHER S, Meisinger C, Linseisen J, Berghaus TM, et al
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors.
Thromb Res. 2022;222:68-74.
PubMed Abstract available

MAXIMILIANO CL, Jaime GC, Erika MH
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban.
Thromb Res. 2022;222:43-48.
PubMed Abstract available

YU JL, Lane M, Roach GD, Morrison SD, et al
Perioperative venous thromboembolism risk considerations in the gender diverse patient - Should we consider more than just estrogen?
Thromb Res. 2022;222:40-42.
PubMed

PRANDONI P, Gabara C, Bilora F, Aibar J, et al
Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry.
Thromb Res. 2022;222:16-19.
PubMed

HASSAN E, Motwani J
Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism.
Thromb Res. 2022;221:92-96.
PubMed Abstract available

November 2022

IDING AFJ, Kremers BMM, Nagy M, Robles AP, et al
Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
Thromb Res. 2022;221:58-64.
PubMed

ARDESHIRROUHANIFARD S, Ellenbogen MI, Segal JB, Streiff MB, et al
Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.
Thromb Res. 2022;221:45-50.
PubMed Abstract available

ARDESHNA NS, Song M, Hyder SN, Grace KA, et al
Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experience.
Thromb Res. 2022;221:73-78.
PubMed Abstract available

TURPIE AGG, Farjat AE, Haas S, Ageno W, et al
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Thromb Res. 2022;222:31-39.
PubMed Abstract available

KAPTEIN FHJ, Stals MAM, Evenhuis RE, Gelderblom H, et al
Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Thromb Res. 2022;221:19-25.
PubMed Abstract available

STEINER D, Nopp S, Weber B, Schlager O, et al
The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study.
Thromb Res. 2022;221:1-6.
PubMed Abstract available

KAPTEIJN MY, Kaptein FHJ, Stals MAM, Klaase EE, et al
Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Thromb Res. 2022;221:10-18.
PubMed Abstract available

WYSOKINSKI WE, Houghton DE, Vlazny DT, Ashrani AA, et al
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
Thromb Res. 2022;221:37-44.
PubMed Abstract available

BJORNHART B, Kristiansen C, Asmussen J, Hansen KH, et al
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
Thromb Res. 2022 Nov 5. pii: S0049-3848(22)00438.
PubMed Abstract available

October 2022

KNUEPPEL P, Bang SH, Troyer C, Barriga A, et al
Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
Thromb Res. 2022;220:91-96.
PubMed Abstract available

SILVEY M, Nguyen ATH, Amankwah EK, McElwaine E, et al
Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium.
Thromb Res. 2022;220:116-120.
PubMed Abstract available

WENGER N, Sebastian T, Beer JH, Mazzolai L, et al
Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Thromb Res. 2022;220:65-71.
PubMed Abstract available

BAIDILDINOVA G, Ten Cate V, Nagler M, Panova-Noeva M, et al
Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
Thromb Res. 2022;220:75-87.
PubMed Abstract available

RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Abdel-Kader-Martin L, Otero-Candelera R, et al
Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review.
Thromb Res. 2022 Oct 11. pii: S0049-3848(22)00405.
PubMed Abstract available

MARTIN KA, Lyleroehr MJ, Cameron KA
Barriers and facilitators to preventing venous thromboembolism in oncology practice.
Thromb Res. 2022;220:21-23.
PubMed

September 2022

GRIS JC, Bourguignon C, Bouvier S, Nouvellon E, et al
Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.
Thromb Res. 2022;219:102-108.
PubMed Abstract available

ALBLAS H, van Kan C, van Het Westeinde SC, Emmering J, et al
Persistent dyspnea after acute pulmonary embolism is related to perfusion defects and lower long-term quality of life.
Thromb Res. 2022;219:89-94.
PubMed

SPEKSNIJDER EM, Hessels LM, Muusses L, Buller HR, et al
Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients.
Thromb Res. 2022;219:109-111.
PubMed

KELLER K, Sivanathan V, Schmitt VH, Ostad MA, et al
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
Thromb Res. 2022;219:77-85.
PubMed Abstract available

LUI B, Wee B, Lai J, Khattak Z, et al
A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant - Has venous thromboembolism treatment become safer?
Thromb Res. 2022;219:112-120.
PubMed Abstract available

YAMASHITA Y, Morimoto T, Kadota K, Takase T, et al
Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.
Thromb Res. 2022;219:30-39.
PubMed Abstract available

SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
Educational differences in mortality but not in risk of recurrence following first-time pulmonary embolism: A Danish nationwide register-based study.
Thromb Res. 2022;219:22-29.
PubMed

LOW SK, Anjum Z, Mahmoud A, Joshi U, et al
Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
Thromb Res. 2022;219:14-21.
PubMed Abstract available

BORST JM, Modi RN, Kirchberg TN, Box K, et al
You're never too old for optimal venous thromboembolism prophylaxis: Re-thinking current trauma guidelines.
Thromb Res. 2022;218:186-188.
PubMed

August 2022

VOIGTLAENDER M, Edler C, Gerling M, Schadler J, et al
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.
Thromb Res. 2022;218:171-176.
PubMed Abstract available

PRANDONI P, Bilora F, Pesavento R, Sancho T, et al
The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry.
Thromb Res. 2022;218:44-47.
PubMed

GORAN K
Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis.
Thromb Res. 2022;218:5-7.
PubMed

MESSI M, Beneyto Afonso C, Stalder O, Mean M, et al
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.
Thromb Res. 2022;218:64-71.
PubMed Abstract available

WANG WD, Wei JP, Gao RQ, Yang QC, et al
A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers.
Thromb Res. 2022;216:52-58.
PubMed Abstract available

WIEGERS HMG, Scheres LJJ, Tahir L, Hutten BA, et al
Risk of venous thromboembolism in women with endometriosis.
Thromb Res. 2022;217:104-106.
PubMed

July 2022

ATA F, Ibrahim WH, Choudry H, Shams A, et al
Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.
Thromb Res. 2022;217:86-95.
PubMed Abstract available

CHOI SH, Nguyen H, Kanjwal S, Ibrahim I, et al
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data.
Thromb Res. 2022;217:60-63.
PubMed

MAHARAJ S, Chang S, Kloecker G, Chesney J, et al
Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
Thromb Res. 2022;217:48-51.
PubMed

ZUIN M, Rigatelli G, Bilato C, Bongarzoni A, et al
Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry.
Thromb Res. 2022;217:15-21.
PubMed

PANCANI R, Villari L, Aquilini F, Palla A, et al
Prognostic role of respiratory failure in acute pulmonary embolism: a prospective multicenter study.
Thromb Res. 2022;217:33-35.
PubMed

NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
Thromb Res. 2022;216:113-119.
PubMed Abstract available

June 2022

FANG MC, Go AS, Prasad PA, Zhou HX, et al
Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
Thromb Res. 2022;216:97-102.
PubMed Abstract available

SHIBAHASHI E, Jujo K, Kuroda S, Matsumoto S, et al
Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
Thromb Res. 2022;216:90-96.
PubMed Abstract available

VEETTIL SK, Harris J, Syeed MS, Thakkinstian A, et al
Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
Thromb Res. 2022;216:74-83.
PubMed Abstract available

SHEN J, Casie Chetty S, Shokouhi S, Maharjan J, et al
Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients.
Thromb Res. 2022;216:14-21.
PubMed Abstract available

GUMAN NAM, van Haaps TF, van Es N, Leeflang MMG, et al
Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.
Thromb Res. 2022;216:11-13.
PubMed

May 2022

BRANDT W, Brown C, Wang TF, Tagalakis V, et al
Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
Thromb Res. 2022;216:8-10.
PubMed Abstract available

SUBHANI M, Sheth A, Ahmed J, Wijayasiri P, et al
Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
Thromb Res. 2022;215:19-29.
PubMed Abstract available

OBRADOVIC S, Subotic B, Dzudovic B, Matijasevic J, et al
Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.
Thromb Res. 2022;214:138-143.
PubMed Abstract available

BIKDELI B, Piazza G, Jimenez D, Muriel A, et al
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
Thromb Res. 2022;214:122-131.
PubMed Abstract available

ROSA V, Chaar CIO, Espitia O, Otalora S, et al
A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome.
Thromb Res. 2022;213:65-70.
PubMed Abstract available

BARBERO E, Manas E, Bikdeli B, Garcia-Ortega A, et al
Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism.
Thromb Res. 2022;214:87-92.
PubMed Abstract available

MONREAL M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al
TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
Thromb Res. 2022;213 Suppl 2:S8-S9.
PubMed Abstract available

BOSCH FTM, Campello E, Henderson MW, Mulder FI, et al
TEMPORARY REMOVAL: OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study.
Thromb Res. 2022;213 Suppl 2:S4.
PubMed Abstract available

OVERVAD TF, Ording AG, Nielsen PB, Piazza G, et al
TEMPORARY REMOVAL: OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors.
Thromb Res. 2022;213 Suppl 2:S4-S5.
PubMed Abstract available

ANTONUCCI E, Barcella L, Russo L, Chistolini A, et al
TEMPORARY REMOVAL: PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry.
Thromb Res. 2022;213 Suppl 2:S39.
PubMed Abstract available

MARTIN AM, Lecumberri R, Souto JC, Aparicio J, et al
TEMPORARY REMOVAL: PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients.
Thromb Res. 2022;213 Suppl 2:S38-S39.
PubMed Abstract available

LOPEZ-NUNEZ JJ, Trujillo-Santos J, Bertoletti L, Lobo JL, et al
TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study.
Thromb Res. 2022;213 Suppl 2:S37-S38.
PubMed Abstract available

SALGADO M, Molina R, Vazquez EB, Martinez E, et al
TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study.
Thromb Res. 2022;213 Suppl 2:S36-S37.
PubMed Abstract available

DONADINI MP, Squizzato A, Ferrazzi P, Maggioni S, et al
TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study.
Thromb Res. 2022;213 Suppl 2:S30-S31.
PubMed Abstract available

ANIJS RJS, Chen Q, Lijfering WM, Cannegieter SC, et al
TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis.
Thromb Res. 2022;213 Suppl 2:S3.
PubMed Abstract available

HAQUE F, Jawad N, Brzuszek A, Birk R, et al
TEMPORARY REMOVAL: PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients.
Thromb Res. 2022;213 Suppl 2:S28.
PubMed Abstract available

FORESTA A, Colacioppo P, Baviera M, Ojeda-Fernandez L, et al
TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
Thromb Res. 2022;213 Suppl 2:S27-S28.
PubMed Abstract available

DAGUENET E, Maison M, Tinquaut F, Giroux EA, et al
TEMPORARY REMOVAL: PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study.
Thromb Res. 2022;213 Suppl 2:S21.
PubMed Abstract available

ALBERTSEN IE, Lyhne NM, Larsen TB, Nielsen PB, et al
TEMPORARY REMOVAL: PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study.
Thromb Res. 2022;213 Suppl 2:S21-S22.
PubMed Abstract available

MORAN LO, Pesantez D, Vazquez EB, Garay DF, et al
TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer.
Thromb Res. 2022;213 Suppl 2:S20.
PubMed Abstract available

GERVASO L, Laffi A, Meneses-Medina MI, Cella CA, et al
TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms.
Thromb Res. 2022;213 Suppl 2:S19-S20.
PubMed Abstract available

JORGENSEN H, Horvath-Puho E, Laugesen K, Braekkan S, et al
TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism.
Thromb Res. 2022;213 Suppl 2:S18-S19.
PubMed Abstract available

SILVA-CARDENAS DC, Pikabea-Diaz F, Zumarraga-Cuesta A, Lopez-Santillan M, et al
TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients.
Thromb Res. 2022;213 Suppl 2:S17.
PubMed Abstract available

CHARLES S, Chaudier A, Fatrara T, Daguenet E, et al
TEMPORARY REMOVAL: PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma.
Thromb Res. 2022;213 Suppl 2:S13.
PubMed Abstract available

TROELSEN FS, Vago EK, Horvath-Puho E, van Es N, et al
TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study.
Thromb Res. 2022;213 Suppl 2:S11.
PubMed Abstract available

JAKOBSEN SS, Frokjaer JB, Fisker RV, Kristensen SR, et al
TEMPORARY REMOVAL: PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients.
Thromb Res. 2022;213 Suppl 2:S11-S12.
PubMed Abstract available

RUIZ M, Martin AM, Font C, Castellon V, et al
TEMPORARY REMOVAL: OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study.
Thromb Res. 2022;213 Suppl 2:S1.
PubMed Abstract available

MCCRAE KR, Swaidani S, Diaz-Montero CM, Khorana AA, et al
Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy.
Thromb Res. 2022;213.
PubMed Abstract available

MOIK F, Ay C
Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies.
Thromb Res. 2022;213 Suppl 1:S58-S65.
PubMed Abstract available

DELLUC A, Robin P
(18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?
Thromb Res. 2022;213 Suppl 1:S42-S45.
PubMed Abstract available

MANTHA S, Rak J
Cancer genetic alterations and risk of venous thromboembolism.
Thromb Res. 2022;213 Suppl 1:S29-S34.
PubMed Abstract available

SANFILIPPO KM
Venous thromboembolism and risk stratification in hematological malignancies.
Thromb Res. 2022;213 Suppl 1:S16-S21.
PubMed Abstract available

April 2022

NOUMEGNI SR, Didier R, Mansourati V, Tromeur C, et al
Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Thromb Res. 2022;214:93-105.
PubMed Abstract available

LIND MM, Johansson M, Sjalander A, Johansson L, et al
Incidence and risk factors of venous thromboembolism in men and women.
Thromb Res. 2022;214:82-86.
PubMed Abstract available

PORFIDIA A, Esposto G, Manzo C, Santini P, et al
No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.
Thromb Res. 2022;214:44-46.
PubMed

RUSSO F, Cianfanelli L, Chieffo A, Galli M, et al
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience.
Thromb Res. 2022;214:40-43.
PubMed

CATELLA J, Bertoletti L, Moustafa F, Nieto JA, et al
Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
Thromb Res. 2022;214:29-36.
PubMed Abstract available

March 2022

ROBERTS LN, Navaratnam AV, Arya R, Briggs TWR, et al
Venous thromboembolism in patients hospitalised with COVID-19 in England.
Thromb Res. 2022;213:138-144.
PubMed Abstract available

VAN DER VLEUTEN CJM, Zwerink LGJM, Klappe EM, de Jong EMGJ, et al
Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?
Thromb Res. 2022;213:30-33.
PubMed

BOVA C, Vigna E, Gentile M, Pignataro FS, et al
Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis.
Thromb Res. 2022;213:43-46.
PubMed

ABUFARHANEH M, Pandya RK, Alkhaja A, Iansavichene A, et al
Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
Thromb Res. 2022;213:47-56.
PubMed Abstract available

PALARETI G, Bignamini AA, Urbanek T, Cini M, et al
Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
Thromb Res. 2022;211:140-146.
PubMed Abstract available

February 2022

ABRUZZO A, Gorantla V, Thomas SE
Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review.
Thromb Res. 2022;212:58-71.
PubMed Abstract available

CATELLA J, Joly M, Pernod G
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
Thromb Res. 2022;213:8.
PubMed

VOCI D, Fedeli U, Farmakis IT, Hobohm L, et al
Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.
Thromb Res. 2022;212:44-50.
PubMed Abstract available

DANIELSBACKA JS, Mannerkorpi K, Olsen MF
Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.
Thromb Res. 2022;212:22-29.
PubMed Abstract available

BONNESEN K, Heide-Jorgensen U, Albertsen LW, Schmidt SAJ, et al
Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism.
Thromb Res. 2022;212:9-18.
PubMed Abstract available

TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
Advances in treatment of chronic thromboembolic pulmonary hypertension.
Thromb Res. 2022;212:30-37.
PubMed Abstract available

BEAUDOIN E, Kaka S, Gagnon E, Durivage A, et al
Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study.
Thromb Res. 2022;212:19-21.
PubMed

BETENSKY M, Kumar R, Hankins JS, Goldenberg NA, et al
Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
Thromb Res. 2022;211:133-139.
PubMed Abstract available

KALAITZOPOULOS DR, Panagopoulos A, Samant S, Ghalib N, et al
Management of venous thromboembolism in pregnancy.
Thromb Res. 2022;211:106-113.
PubMed Abstract available

January 2022

KALAYCI A, Gibson CM, Hernandez AF, Hull RD, et al
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
Thromb Res. 2022;211:63-69.
PubMed Abstract available

SHEN Y, Zhang Y, Xiong Y, Zhang Z, et al
Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism.
Thromb Res. 2022;211:49-55.
PubMed Abstract available

POHL KR, Hobohm L, Krieg VJ, Sentler C, et al
Impact of thyroid dysfunction on short-term outcomes and long-term mortality in patients with pulmonary embolism.
Thromb Res. 2022;211:70-78.
PubMed Abstract available

CABALLERO-ERASO C, Lopez-Ramirez C, Marin-Romero S, Carrera-Cueva C, et al
Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study.
Thromb Res. 2022;211:81-84.
PubMed

BIKDELI B, Moustafa F, Nieto JA, Lee AI, et al
Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
Thromb Res. 2022;211:10-18.
PubMed Abstract available

December 2021

PETRELLI F, Cabiddu M, Borgonovo K, Parati MC, et al
Osimertinib-related venous thromboembolism in non small lung cancer.
Thromb Res. 2021;210:63-66.
PubMed

SIMARD C, Malhame I, Skeith L, Carson MP, et al
Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.
Thromb Res. 2021;210:20-25.
PubMed Abstract available

WANG L, Wei S, Zhou B, Wu S, et al
Corrigendum to "A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors" [Thromb. Res. 202, June 2021, 52-58].
Thromb Res. 2021;210:4-5.
PubMed

SONNE-HOLM E, Kjaergaard J, Bang LE, Fosbol E, et al
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999-2018.
Thromb Res. 2021;210:12-19.
PubMed Abstract available

ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
Thromb Res. 2021;209:105.
PubMed

ZUIN M, Engelen MM, Barco S, Spyropoulos AC, et al
Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.
Thromb Res. 2021;209:94-98.
PubMed

DE WINTER MA, Timmers T, Hovens MMC, Iglesias Del Sol A, et al
Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial.
Thromb Res. 2021;209:86-93.
PubMed Abstract available

BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545.
PubMed

November 2021

VERMA AA, Masoom H, Pou-Prom C, Shin S, et al
Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients.
Thromb Res. 2021;209:51-58.
PubMed Abstract available

BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
Thromb Res. 2021;208:190-197.
PubMed Abstract available

ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
Thromb Res. 2021;208:170-172.
PubMed

GIRAUD M, Catella J, Cognet L, Helfer H, et al
Management of acute venous thromboembolism in patients taking antiplatelet therapy.
Thromb Res. 2021;208:156-161.
PubMed Abstract available

GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
Thromb Res. 2021;208:106-111.
PubMed Abstract available

TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
PubMed

October 2021

LEE A, Oley F Jr, Lo M, Fong R, et al
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
Thromb Res. 2021;208:148-155.
PubMed Abstract available

NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
Thromb Res. 2021;208:79-82.
PubMed Abstract available

HILL H, Robinson M, Lu L, Slaughter D, et al
Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
Thromb Res. 2021;208:71-78.
PubMed Abstract available

HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
Thromb Res. 2021;208:121-126.
PubMed Abstract available

LI A, Brandt W, Brown C, Wang TF, et al
Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
Thromb Res. 2021;208:58-65.
PubMed Abstract available

HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
Thromb Res. 2021;208:52-57.
PubMed Abstract available

LI J, Yi J, Hua L, Su Y, et al
Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
Thromb Res. 2021;208:45-51.
PubMed Abstract available

BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
Thromb Res. 2021;208:39-44.
PubMed Abstract available

DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
Thromb Res. 2021;208:4-10.
PubMed Abstract available

PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
Thromb Res. 2021;207:150-157.
PubMed Abstract available

BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
Thromb Res. 2021;206:66-75.
PubMed Abstract available

September 2021

TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
Thromb Res. 2021;207:143-149.
PubMed Abstract available

LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
Thromb Res. 2021;207:113-115.
PubMed

MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
Thromb Res. 2021;207:116-122.
PubMed Abstract available

GABET A, Grave C, Tuppin P, Emmerich J, et al
Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
Thromb Res. 2021;207:67-74.
PubMed Abstract available

OHASHI Y, Ikeda M, Kunitoh H, Sasako M, et al
One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
Thromb Res. 2021 Sep 21. pii: S0049-3848(21)00464.
PubMed Abstract available

OAKES M, Arastu A, Kato C, Somers J, et al
Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
Thromb Res. 2021;207:96-98.
PubMed Abstract available

August 2021

STESSEL B, Peeters J, Bruckers L, Nulens M, et al
Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
Thromb Res. 2021;206:139-141.
PubMed

HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
Thromb Res. 2021;206:128-130.
PubMed

YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
Thromb Res. 2021;206:99-103.
PubMed Abstract available

WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
Pulmonary embolism and deep vein thrombosis: Similar but different.
Thromb Res. 2021;206:88-98.
PubMed Abstract available

JOHNSON SA, Jones AE, Young E, Jennings C, et al
A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Thromb Res. 2021;206:120-127.
PubMed Abstract available

FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
Media portrayals of pulmonary embolism.
Thromb Res. 2021;206:52-54.
PubMed

FILIPPI L, Sartori M, Facci M, Trentin M, et al
Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
Thromb Res. 2021;206:29-32.
PubMed Abstract available

HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
Thromb Res. 2021;207:134-139.
PubMed Abstract available

KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
Thromb Res. 2021;204:114-122.
PubMed Abstract available

July 2021

HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
Thromb Res. 2021;206:36-41.
PubMed Abstract available

GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
Thromb Res. 2021;205:63-69.
PubMed Abstract available

DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
"Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
Thromb Res. 2021;205:56-62.
PubMed Abstract available

LACHANT D, Roto D, Rappaport S, Prasad P, et al
Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
Thromb Res. 2021;205:40-43.
PubMed

METRA B, Summer R, Brooks SE, George G, et al
Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
Thromb Res. 2021;205:84-91.
PubMed Abstract available

GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
Thromb Res. 2021;205:11-16.
PubMed Abstract available

COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
Thromb Res. 2021;206:1-4.
PubMed

RIGATELLI G, Zuin M
Not all patent foramen ovales are alike!
Thromb Res. 2021;203:81.
PubMed

SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
Thromb Res. 2021;205:17-23.
PubMed Abstract available

June 2021

JIN MC, Sussman ES, Feng AY, Han SS, et al
Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
Thromb Res. 2021;204:126-133.
PubMed Abstract available

RIVERA-LEBRON B, Bauersachs R
Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
Thromb Res. 2021;204:101-107.
PubMed Abstract available

KO D, Preis SR, Johnson AD, Vasan RS, et al
Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
Thromb Res. 2021;204:108-113.
PubMed Abstract available

SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
Thromb Res. 2021;204:81-87.
PubMed Abstract available

YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
Difference between Japanese and White patients with acute pulmonary embolism.
Thromb Res. 2021;204:52-56.
PubMed

BAN L, Abdul Sultan A, West J, Tata LJ, et al
External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
PubMed Abstract available

BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
Management of high-risk pulmonary embolism in pregnancy.
Thromb Res. 2021;204:57-65.
PubMed Abstract available

MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
Cancer risk after a venous thrombotic event - RIETE score.
Thromb Res. 2021;202:43-44.
PubMed

VALERIO L, Corsi G, Granziera S, Holm K, et al
Sex differences in Lemierre syndrome: Individual patient-level analysis.
Thromb Res. 2021;202:36-39.
PubMed

May 2021

RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
Thromb Res. 2021;204:9-12.
PubMed Abstract available

PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
Thromb Res. 2021;204:29-31.
PubMed

LE MAO R, Tromeur C, Couturaud F
A case of acute pulmonary embolism with severe haemoptysis.
Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
PubMed Abstract available

NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
Thromb Res. 2021;203:172-185.
PubMed Abstract available

GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
Thromb Res. 2021;203:155-162.
PubMed Abstract available

BARATH B, Bogati R, Miklos T, Kallai J, et al
Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb Res. 2021;203:110-116.
PubMed Abstract available

ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
Thromb Res. 2021;203:93-100.
PubMed Abstract available

JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
Thromb Res. 2021;203:190-195.
PubMed Abstract available

MUMOLI N, Conte G, Cei M, Vitale J, et al
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
Thromb Res. 2021;203:82-84.
PubMed

BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
Thromb Res. 2021;203:74-80.
PubMed Abstract available

HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
Thromb Res. 2021;201:18-22.
PubMed Abstract available

April 2021

BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
Thromb Res. 2021;202:155-161.
PubMed Abstract available

KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
Pulmonary infarction in acute pulmonary embolism.
Thromb Res. 2021;202:162-169.
PubMed Abstract available

HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
Thromb Res. 2021;202:145-147.
PubMed

March 2021

DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
Thromb Res. 2021;202:128-133.
PubMed Abstract available

YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
Lifestyle factors and venous thromboembolism in two cohort studies.
Thromb Res. 2021;202:119-124.
PubMed Abstract available

BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
Thromb Res. 2021;202:105-107.
PubMed

SKEITH L, Le Gal G, Rodger MA
Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
Thromb Res. 2021;202:134-138.
PubMed Abstract available

KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
Thromb Res. 2021;202:77-83.
PubMed Abstract available

ALLEN S, Chan L, Masic D, Porcaro K, et al
Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
Thromb Res. 2021;202:96-99.
PubMed

PETRELLI F, Solinas C
Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
PubMed

AKTAA S, Wu J, Nadarajah R, Rashid M, et al
Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Thromb Res. 2021;202:17-23.
PubMed Abstract available

LACUT K, Le Moigne E, Couturaud F, Font C, et al
Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
Thromb Res. 2021;202:59-66.
PubMed Abstract available

ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
Thromb Res. 2021;202:31-35.
PubMed Abstract available

FRERE C, Ederhy S, Salem JE
Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
PubMed

WANG L, Wei S, Zhou B, Wu S, et al
A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
Thromb Res. 2021;202:52-58.
PubMed Abstract available

KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
Thromb Res. 2021;199:143-148.
PubMed Abstract available

ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
The effect of race on composite thrombotic events in patients with COVID-19.
Thromb Res. 2021;199:10-13.
PubMed Abstract available

February 2021

WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
Three-month follow-up of pulmonary embolism in patients with COVID-19.
Thromb Res. 2021;201:113-115.
PubMed

GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
Thromb Res. 2021;201:131-138.
PubMed Abstract available

ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
Thromb Res. 2021;201:63-72.
PubMed Abstract available

JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
Thromb Res. 2021;201:90-99.
PubMed Abstract available

SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
Thromb Res. 2021;201:1-5.
PubMed Abstract available

MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
Thromb Res. 2021;200:99-101.
PubMed

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
Thromb Res. 2021;200:130-132.
PubMed

January 2021

STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
Thromb Res. 2021;200:48-50.
PubMed

BECATTINI C, Cimini LA, Carrier M
Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
Thromb Res. 2021;200:41-47.
PubMed Abstract available

BOIETTI B, Fili S, Peuchot V, Tabares A, et al
Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
PubMed

PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
Thromb Res. 2021;199:101-105.
PubMed Abstract available

GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
Venous-thromboembolism in elderly patients with acute myeloid leukemia.
Thromb Res. 2021;200:9-11.
PubMed

DESANCHO M, Munn JE, Billett HH, Cheng D, et al
Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
Thromb Res. 2021;200:23-29.
PubMed Abstract available

DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
Thromb Res. 2021;199:85-96.
PubMed Abstract available

MURGIER M, Fouillet L, Ollier E, Merah A, et al
Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
Thromb Res. 2021;199:106-109.
PubMed

SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
Thromb Res. 2021;199:97-100.
PubMed

AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
Thromb Res. 2021;199:123-131.
PubMed Abstract available

MOIK F, Makatsariya A, Ay C
Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
Thromb Res. 2021;199:38-42.
PubMed Abstract available

MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
Thromb Res. 2021;197:112-113.
PubMed

PANCANI R, Villari L, Foci V, Parri G, et al
Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
Thromb Res. 2021;197:44-47.
PubMed Abstract available

December 2020

ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
Thromb Res. 2020;199:14-18.
PubMed Abstract available

ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
Thromb Res. 2020;199:59-66.
PubMed Abstract available

NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
Thromb Res. 2020;199:82-84.
PubMed

VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
Thromb Res. 2020;199:32-34.
PubMed

RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
Thromb Res. 2020;198:135-138.
PubMed Abstract available

GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
Thromb Res. 2020;198:163-170.
PubMed Abstract available

DE WIT K, Linkins LA
A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
Thromb Res. 2020;198:83-85.
PubMed Abstract available

MIAO R, Dong X, Gong J, Wang Y, et al
Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
Thromb Res. 2020;198:122-131.
PubMed Abstract available

ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
Thromb Res. 2020;198:103-114.
PubMed Abstract available

WANG L, Chen F, Bai L, Yi Q, et al
In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
Thromb Res. 2020;196:541-542.
PubMed

PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
Thromb Res. 2020;196:355-358.
PubMed Abstract available

November 2020

KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
Thromb Res. 2020;198:26-33.
PubMed Abstract available

LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
Thromb Res. 2020;198:1-6.
PubMed Abstract available

POLI D, Migliaccio L, Antonucci E, Biancone L, et al
Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
Thromb Res. 2020;198:52-54.
PubMed

SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
Thromb Res. 2020;198:34-39.
PubMed Abstract available

STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
Thromb Res. 2020;197:160-164.
PubMed Abstract available

BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
Thromb Res. 2020;197:144-152.
PubMed Abstract available

PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
Thromb Res. 2020;197:94-99.
PubMed Abstract available

ROBERGE G, Delluc A
Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
Thromb Res. 2020;197:77-83.
PubMed Abstract available

ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
Thromb Res. 2020;197:48-55.
PubMed Abstract available

PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
Thromb Res. 2020;197:8-12.
PubMed Abstract available

MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
Thromb Res. 2020;195:228-230.
PubMed

ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
Thromb Res. 2020;198:40-48.
PubMed Abstract available

October 2020

SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
Thromb Res. 2020;196:539-540.
PubMed

SPEED V, Patel JP, Roberts LN, Patel RK, et al
UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
Thromb Res. 2020;197:16-19.
PubMed

BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
Thromb Res. 2020;196:486-490.
PubMed Abstract available

VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
Thromb Res. 2020;196:435-436.
PubMed

HAN X, Li C, Zhang S, Hou X, et al
Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
Thromb Res. 2020;196:500-509.
PubMed Abstract available

VALERIO L, Corsi G, Sebastian T, Barco S, et al
Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
Thromb Res. 2020;196:494-499.
PubMed Abstract available

CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
Thromb Res. 2020;196:476-482.
PubMed Abstract available

GERSTEIN L, Koolian M, Schwartz BC
Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
Thromb Res. 2020;196:463-465.
PubMed

DOYLE AJ, Thomas W, Retter A, Besser M, et al
Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
Thromb Res. 2020;196:454-456.
PubMed

SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
Thromb Res. 2020;196:444-453.
PubMed Abstract available

RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
Thromb Res. 2020;194:220-221.
PubMed

September 2020

YANG M, Qi J, Tang Y, Wu D, et al
Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
Thromb Res. 2020;196:410-413.
PubMed

MA SG, Hu J, Huang Y
The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
Thromb Res. 2020;196:325-334.
PubMed Abstract available

CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
Thromb Res. 2020;196:318-321.
PubMed

CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Thromb Res. 2020;196:349-354.
PubMed Abstract available

DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Thromb Res. 2020;196:308-312.
PubMed Abstract available

PAVONI V, Gianesello L, Pazzi M, Stera C, et al
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
Thromb Res. 2020;196:313-317.
PubMed Abstract available

DELATE T, Charlu M, Zhu S, Pai A, et al
Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
Thromb Res. 2020;196:367-370.
PubMed Abstract available

MIRO O, Llorens P, Aguirre A, Lozano L, et al
Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
Thromb Res. 2020;196:322-324.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.